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lography have we come to realize that in carrying outStudying Topoisomerases
their three-step mechanism, topoisomerases undergoin the Fourth Dimension various conformational changes as they pass through
a series of transient intermediate states. Two recent
reports reveal new details about this pathway for type
IA and type IB enzymes. Perry and Mondrago´n (2003)Two recent studies on DNA topoisomerases combine
determined the structure of a type IA enzyme complexedthe power of biochemistry and structural biology to
to single-stranded DNA and provide structural evidencegain new insight at the atomic level into how these
for a new conformational intermediate. Tian and cowork-enzymes interact with DNA (Perry and Mondrago´n,
ers examine the interactions of a type IB enzyme with2003 [Structure, Nov. 2003]; Tian et al., 2004 [this
modified DNA substrates to provide evidence that pro-issue]).
tein contacts with the phosphate backbone drive con-
formational changes in the enzyme. Both papers ad-It is an important fact of life that DNA is flexible. Thus
dress how enzyme and DNA contact each other, andit can withstand the extreme compaction necessary to
how these contacts change over the course of the re-pack inside living cells, as well as the torsional strain
action.
that arises during processes like transcription and repli-
Topoisomerases I and III from E. coli show a similar
cation. In response to these stresses, the double-helical
padlock-shaped structure bearing a central hole, which
axis of DNA coils in space, a process termed supercoil-
is thought to take up and hold the passed DNA strand
ing. Cells rely on enzymes called topoisomerases to until after religation (Lima et al., 1994). The structure
remove excessive supercoiling while maintaining suffi- of topoisomerase III complexed with a single-stranded
cient supercoiling to ensure a stably compact genome. octanucleotide (Changela et al., 2001) provided the first
Topoisomerases participate in nearly every cellular glimpse of a type IA enzyme bound to DNA (Figure 1A).
process that involves DNA, including transcription, repli- The structure revealed considerable conformational
cation, recombination, and chromosome segregation changes in the protein relative to the apoenzyme (Figure
(reviewed in Champoux, 2001). All topoisomerases use 1B), including a reorientation of the active site pocket
a three-step mechanism of cleavage, strand passage, to bring the catalytic tyrosine into position to attack the
and religation. In the first step, a nucleophilic tyrosine scissile bond. This conformation is thought to corre-
attacks the phosphodiester backbone, cleaving the DNA spond to a point in the reaction pathway just before
and creating a covalent intermediate of protein-DNA cleavage or just after religation. The more recent struc-
termed the “cleavage complex.” Type I topoisomerases ture of topoisomerase I complexed with a single-
cleave one strand of the duplex, whereas type II en- stranded oligonucleotide (Perry and Mondrago´n, 2003)
zymes cleave both strands. Type I enzymes are further provides direct evidence for another transient intermedi-
divided into type IA and IB, depending on whether they ate. In contrast to the topoisomerase III complex, this
attach to the 5 or 3 phosphate of the DNA, respectively. structure is almost unchanged from that of the apoen-
In the cleavage complex, the free ends of the cleaved zyme. The active site pocket is not positioned for cataly-
strand(s) are separated and the other strand of the du- sis, suggesting that this conformation represents an in-
plex (in the type I case) or another region of duplex (in termediate just after the initial DNA binding or just prior
the type II case) passes through this gap. Finally the to its release.
backbone of the cleaved DNA is religated and the duplex These crystal structures, together with elegant bio-
is released. chemical data (Li et al., 2001), provide strong evidence
Biochemical studies proved powerful enough to pro- that type IA topoisomerases use a multistep pathway
vide us with the general mechanism of topoisomerases, to cleave one DNA strand and pass the other into the
central hole of the enzyme. An important goal now is tobut only by combining biochemistry with X-ray crystal-
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Figure 1. Structural Snapshots of DNA Topo-
isomerase Intermediates
(A) Structure of E. coli topoisomerase III (type
IA, PDB entry 1i7d) showing the large central
hole, which is thought to take up a single
strand of DNA during the reaction cycle.
Bound DNA cocrystallized with the protein is
shown with the phosphate backbone in red
and bases in gray. The color of the protein is
ramped from the N terminus in cyan to the C
terminus in dark blue.
(B) Comparison of this structure (blue) with
that of the apoenzyme (yellow, PDB entry
1d6m) shows the conformational changes of
the protein upon DNA binding. This confor-
mation is likely to correspond to a state imme-
diately before or after cleavage.
(C) Evidence for the opening of the DNA gate
during strand passage was provided by the
crystal structure of a gate-forming fragment
of E. coli topoisomerase I. Superimposing the
fragment (blue, PDB entry 1cyy, chain C) with
the catalytic domain of topoisomerase I (gray,
PDB entry 1ecl) suggests that the gate
“splays out” to allow the passed strand to
enter the central hole. The active site tyrosine
is highlighted in red.
(D) Structure of the human topoisomerase IB
(PDB entry 1a36) complexed with a 22 base
pair double-stranded substrate (red back-
bone, gray bases). Despite their similar func-
tions, type IA and IB topoisomerases are
structurally and mechanistically distinct.
visualize the strand passage step. How does the protein positioned for catalysis in the structure of the free vac-
cinia enzyme, while they were ordered and contactinggate open up to permit strand passage, all the while
remaining covalently attached to the 5 end of the DNA in the structure of the human enzyme. This sug-
gests that the initial binding to DNA triggers the forma-cleaved DNA strand? The structure of a topoisomerase
I fragment encompassing the DNA gate (Feinberg et al., tion of a catalytically competent enzyme.
Further evidence for substrate-induced conforma-1999) provided some clues by suggesting the existence
of two hinge regions that may help the gate to swing tional changes in type IB enzymes comes from a report
by Tian and coworkers in the current issue of Structure.open (Figure 1C).
Type IB topoisomerases, which include all known They measured the cleavage and religation rates of vac-
cinia topoisomerase IB on DNA substrates where theeukaryotic type I enzymes, show no significant se-
quence or structural homology to their type IA counter- nonbridging oxygens of the backbone were systemati-
cally changed to methylphosphonate to eliminate theparts. These enzymes encircle double-stranded DNA
(Figure 1D) and perform strand passage using a mecha- negative charge of the phosphodiester. Not only were
they able to determine which phosphates interact withnism of “controlled rotation”(Champoux, 2001). Topo-
isomerase IB from vaccinia virus has been crystallized the protein, but they were also able to determine whether
the interaction is important for the cleavage step, theon its own (Cheng et al., 1998), and human topoisomer-
ase IB has been crystallized in covalent and noncovalent religation step, or both. By identifying positions along
the substrate where the methylphosphonate substitu-complexes with DNA (Redinbo et al., 1998; Stewart et
al., 1998). The noncovalent complex probably corre- tion slows the cleavage rate but not the religation rate,
the authors provide evidence that DNA binding is impor-sponds to a reaction intermediate just prior to cleavage,
whereas the covalent complex corresponds to an inter- tant for getting the enzyme to configure its active site
for the cleavage step.mediate just after cleavage. Comparing the free and
complexed structures provides a model for the early Because some of the methylphosphonate-substituted
DNAs studied by Tian et al. react very slowly with thestages of the type IB reaction pathway: several of the
active site residues conserved between the vaccinia vaccinia enzyme, they may prove useful for capturing
reaction intermediates along the type IB pathway. In-and human enzymes were disordered or inappropriately
Previews
9
Selected Readingdeed, the use of modified DNA allowed the human en-
zyme to be crystallized in a cleavage complex (Redinbo
Champoux, J.J. (2001). Annu. Rev. Biochem. 70, 369–413.et al., 1998). Perhaps a similar approach can be success-
ful with type IA enzymes. The need for novel strategies Changela, A., DiGate, R.J., and Mondrago´n, A. (2001). Nature 411,
1077–1081.to trap topoisomerase intermediates reflects the central
challenge for the structural biology of any enzyme that Cheng, C., Kussie, P., Pavletich, N., and Shuman, S. (1998). Cell 92,
works by a multistep mechanism: just as important as 841–850.
knowing the three-dimensional structure is understand- Feinberg, H., Lima, C.D., and Mondrago´n, A. (1999). Nat. Struct.
ing how that structure changes in the fourth dimension Biol. 6, 918–922.
of time.
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